TV.PHARM PHARMACEUTICAL JOINT STOCK COMPANY

Similar suppliers you may like

Imexpharm Pharmaceutical Joint Stock Company

🇻🇳 Vietnam

1977

1001-2000 people

Manufacturer/Distributor

High capacity factory

Established brand

Large enterprise group

OEM manufacturer

Shipments

Key customer

BURYAT OMBOL

Key market

Europe

Description

Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide. Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions. As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.

Thực Phẩm Bảo Vệ Sức Khỏe

Vitamin & khoáng chất

Nhóm dùng ngoài

Diệt trừ ký sinh trùng

Tiểu đường

Tiêu hóa gan mật

Giãn mạch ngoại biên và hoạt hóa não

Kháng Histamin & Kháng dị ứng

Hệ hô hấp

Giảm đau - kháng viêm - hạ sốt

Cơ xương khớp

Mắt

Vidipha Central Pharmaceutical Joint Stock Company

🇻🇳 Vietnam

2003

101-200 people

Manufacturer/Distributor/Service Company

Established brand

OEM manufacturer

Shipments

Key customer

MED AGRO

Key market

🇻🇳 Vietnam

Description

Vidipha Central Pharmaceutical Joint Stock Company is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. With a history spanning 48 years and over two decades operating as a joint-stock enterprise, the company has established itself as a key player in the healthcare sector, employing between 101 and 200 professionals. Vidipha operates a dedicated manufacturing facility and has maintained a GMP-certified quality system for over 23 years, ensuring high standards across its diverse product portfolio. The company specializes in the production of treatment drugs, health protection foods, and medical equipment. Its extensive pharmaceutical range includes antibiotics, analgesics, antipyretics, antivirals, antihistamines, and specialized treatments for cardiovascular, respiratory, gastrointestinal, and dermatological conditions. Notable products include Acyclovir, Amoxycilin, and Gludipha. Beyond manufacturing, Vidipha offers OEM services, drug storage, testing, and technology transfer consulting. The company is listed on the Ho Chi Minh Stock Exchange (VDP) and serves a network of over 10,000 customers through five regional branches. Its manufacturing capabilities cover various dosage forms, including tablets, liquids, powders, and ointments.